No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Carcinoma / etiology
-
Carcinoma / pathology
-
Carcinoma / therapy*
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Humans
-
Neoadjuvant Therapy / methods
-
Neoplasm Invasiveness
-
Risk Factors
-
Urinary Bladder Neoplasms / etiology
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / therapy*